LTRN
Price:
$3.09
Market Cap:
$33.32M
Lantern Pharma Inc., a clinical stage biotechnology company, focuses on artificial intelligence, machine learning, and genomic data to streamline the drug development process. Its advanced drug candidate is LP-100, which is in phase II clinical trials to treat metastatic, castration-resistant, and prostate cancer. The company also develops LP-300 as a combination therapy for non or never-smokers with non-small cell lung cancer adenocarcinoma. In addition, its preclinical development drug candidate is LP-184, an alkylating agent that damages DNA in cancer cells that overexpress certain biomarkers or that harbor mutations in DNA repair pathways. Further, the company operates ADC program, an an...[Read more]
Industry
Biotechnology
IPO Date
2020-06-11
Stock Exchange
NASDAQ
Ticker
LTRN
According to Lantern Pharma Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 25.51M. This represents a change of -42.04% compared to the average of 44.02M of the last 4 quarters.
The mean historical Enterprise Value of Lantern Pharma Inc. over the last ten years is 62.39M. The current 25.51M Enterprise Value has changed 3.99% with respect to the historical average. Over the past ten years (40 quarters), LTRN's Enterprise Value was at its highest in in the June 2021 quarter at 102.17M. The Enterprise Value was at its lowest in in the June 2019 quarter at 0.
Average
62.39M
Median
64.07M
Minimum
24.70M
Maximum
100.63M
Discovering the peaks and valleys of Lantern Pharma Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 8.87%
Maximum Annual Enterprise Value = 100.63M
Minimum Annual Increase = -64.52%
Minimum Annual Enterprise Value = 24.70M
Year | Enterprise Value | Change |
---|---|---|
2023 | 24.70M | -12.99% |
2022 | 28.39M | -20.48% |
2021 | 35.70M | -64.52% |
2020 | 100.63M | 8.87% |
2019 | 92.43M | -0.08% |
The current Enterprise Value of Lantern Pharma Inc. (LTRN) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
29.60M
5-year avg
56.37M
10-year avg
62.39M
Lantern Pharma Inc.’s Enterprise Value is greater than TFF Pharmaceuticals, Inc. (-2265301.00), less than Generation Bio Co. (146.60M), greater than Lyra Therapeutics, Inc. (22.84M), less than Immunome, Inc. (524.38M), less than Cue Biopharma, Inc. (39.82M),
Company | Enterprise Value | Market cap |
---|---|---|
-2265301.00 | $288.80K | |
146.60M | $74.47M | |
22.84M | $11.31M | |
524.38M | $677.22M | |
39.82M | $62.73M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Lantern Pharma Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Lantern Pharma Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Lantern Pharma Inc.'s Enterprise Value?
What is the highest Enterprise Value for Lantern Pharma Inc. (LTRN)?
What is the 3-year average Enterprise Value for Lantern Pharma Inc. (LTRN)?
What is the 5-year average Enterprise Value for Lantern Pharma Inc. (LTRN)?
How does the current Enterprise Value for Lantern Pharma Inc. (LTRN) compare to its historical average?